Try Ask OE! Our NEW Advanced AI Enabled Search Dive into the Largest Database of Musculoskeletal Evidence Ask OE
Make a selection below to explore our full database of 8 results matching: "Cannabidiol"
ACE Reports
(8 Reports)
ACE Reports
Originals
(0 Articles)
Originals
Podcasts
(0 Videos)
Podcasts
Our AI driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Close Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
to
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
to
ACE Report Image
Arthroplasty
COA 2025: Cannabidiol to Prevent Persistent Post-Surgical Pain Following Total Knee Arthroplasty
ACE Report Image
Osteoarthritis
Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.
Lancet Reg Health Eur. 2023 01-Nov;():. 10.1016/j.lanepe.2023.100777
ACE Report Image
Shoulder & Elbow
Buccally Absorbed Cannabidiol Shows Significantly Superior Pain Control and Improved Satisfaction Immediately After Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, Double-Blinded, Randomized Trial
Am J Sports Med. 2022 01-Jul;():. 10.1177/03635465221109573
ACE Report Image
Osteoarthritis
High Impact
This study has been identified as potentially high impact. OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself. Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone. This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.

Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
Pain. 2022 01-Jun;():. 10.1097/j.pain.0000000000002466
ACE Report Image
Shoulder & Elbow
Buccally Absorbed Cannabidiol Shows Promise in Treating Pain and Improving Satisfaction Immediately Following Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, DoubleBlinded, Randomized Trial
ACE Report Image

The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain
Med J Aust. 2021 01-May;():. 10.5694/mja2.51014
ACE Report Image
High Impact
This study has been identified as potentially high impact. OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself. Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone. This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.

Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
Psychopharmacology. 2020 ;():. 10.1007/s00213-019-05442-6
ACE Report Image
High Impact
This study has been identified as potentially high impact. OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself. Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone. This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
Clin Ther. 2007 Sep;29(9):2068-79
Welcome Back!
Forgot Password?
Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Help us Improve

Provide additional feedback (optional)

Submit Feedback

Thank You!

Thank you for providing valuable feedback regarding your recent interaction with Ask OE.

Return to Ask OE